TCL Archive Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women November 26, 2010
TCL Archive Also in this 8-page issue: Tony Hunter, Raymond DuBois win AACR Landon prizes. March 5, 2004
TCL Archive Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial December 25, 2009
TCL Archive “The Working Group urges NCI to reconsider its current budget to determine whether the 25 percent devoted to the IRP is appropriate.” July 7, 1995